Vegetative (Atypical) Bacterial Vaginosis

Overview

Vegetative (atypical) bacterial vaginosis (BV) is a variant of the more common form of bacterial vaginosis in which the vaginal microbiome is dominated by *Gardnerella* and other anaerobic bacteria, but the clinical presentation is milder or “atypical.” Women may have few or no obvious discharge or odor, yet laboratory testing reveals an imbalance of vaginal flora. Because the symptoms are subtle, many women remain undiagnosed until the condition is investigated for another reason (e.g., infertility work‑up or routine pelvic exam).

• Who it affects: Primarily reproductive‑aged women (15‑45 years), but it can occur post‑menopause.
• Prevalence: BV overall affects ≈ 1 in 3 women of child‑bearing age worldwide.^[1] Atypical or “vegetative” presentations account for an estimated 10‑20 % of those cases, making it a clinically important but often overlooked subset.^[2]

Symptoms

Symptoms may be absent or very mild, which is why the condition is sometimes called “asymptomatic BV.” When present, they typically include:

• Thin, watery vaginal discharge: Often clear or slightly grayish; may be difficult for the patient to notice.
• Weak or intermittent fishy odor: May be more evident after intercourse or during menstruation.
• Vulvar itching or mild irritation: Usually less intense than with Candida infections.
• Burning during urination: Caused by irritation of the urethral opening.
• Pelvic discomfort: A vague pressure or fullness rather than sharp pain.
• Post‑coital symptoms: Slight increase in discharge or odor after sex.

Because many women experience none of these, routine screening (especially in pregnancy) is recommended if risk factors are present.

Causes and Risk Factors

Underlying cause

BV occurs when the normal lactobacilli‑dominated vaginal ecosystem is disrupted, allowing anaerobic bacteria (e.g., Gardnerella vaginalis, Atopobium vaginae, Mobiluncus spp.) to proliferate. In the vegetative form, the shift is less pronounced, but the same imbalance is present.

Key risk factors

• Sexual activity: Multiple or new partners, and condoms used inconsistently, increase exposure to bacterial flora.
• Douching or intravaginal cleansing: These practices disturb the natural lactobacilli.
• Smoking: Nicotine alters vaginal pH and bacterial composition.
• Hormonal changes: Pregnancy, oral contraceptives, and menopause can affect the microbiome.
• Antibiotic use: Systemic antibiotics may eradicate lactobacilli while sparing resistant anaerobes.
• Intrauterine device (IUD) use: Associated with a modest increase in BV risk.

Diagnosis

Because vegetative BV may lack classic symptoms, a combination of clinical assessment and laboratory testing is essential.

Clinical evaluation

• Focused history (sexual activity, douching, recent antibiotics, menstrual cycle).
• Physical exam including speculum visualization.

Laboratory tests

1. Amsel criteria (modified): Traditionally requires ≥3 of 4 findings (homogeneous discharge, pH > 4.5, “whiff” test, clue cells). For vegetative BV, clinicians may accept 2 criteria plus a positive lab test.
2. Microscopy for clue cells: Epithelial cells covered with bacteria; the hallmark of BV.
3. Nugent score (Gram stain): A numeric scoring system (0‑10) based on the relative abundance of lactobacilli vs. Gardnerella/Mobiluncus. Scores 4‑6 are considered “intermediate” and often represent the vegetative form.
4. DNA probe or PCR panels: Detect specific bacterial DNA (e.g., *Gardnerella* spp.) and have higher sensitivity for atypical presentations.
5. pH testing: Vaginal pH > 4.5 supports the diagnosis.

In pregnancy, routine screening is advised because BV increases the risk of preterm birth, even when symptoms are absent.^[3]

Treatment Options

Treatment aims to restore a lactobacilli‑dominant flora and alleviate any symptoms. The choice depends on severity, pregnancy status, and patient preference.

First‑line antibiotic regimens

• Metronidazole 500 mg orally twice daily for 7 days (or 2 g single dose). Effective in >80 % of cases.^[4]
• Clindamycin 300 mg orally twice daily for 7 days** – alternative for metronidazole‑intolerant patients.
• Metronidazole vaginal gel 0.75 % (5 g) once daily for 5 days – useful for women who prefer a topical route.

Treatment for vegetative/atypical BV

Because the bacterial load may be lower, some clinicians use a shorter regimen (e.g., metronidazole 500 mg once daily for 5 days) plus a probiotic adjunct.

Adjunctive therapies

• Probiotic supplementation: Lactobacillus rhamnosus GR‑1 and L. reuteri RC‑14 taken orally for 30 days have shown modest benefit in maintaining remission.^[5]
• Acidifying agents: Vaginal pH‑balancing gels (lactic acid) may help re‑establish an acidic environment.

Special considerations

• Pregnancy: Metronidazole 500 mg twice daily for 7 days is considered safe (Category B). Clindamycin is also acceptable.
• Recurrent BV (≥3 episodes/year): Consider weekly metronidazole 500 mg for 2 weeks, then twice‑weekly maintenance for 3 months, combined with probiotics.
• Allergy or intolerance: Use clindamycin or azithromycin (off‑label) under provider guidance.

Living with Vegetative (Atypical) Bacterial Vaginosis

Even when symptoms are mild, the condition can affect quality of life. The following tips help manage daily concerns:

• Maintain good genital hygiene: Wash the external vulva with warm water only; avoid scented soaps, douches, and harsh wipes.
• Wear breathable underwear: Cotton or moisture‑wicking fabrics reduce moisture buildup.
• Practice safe sex: Use condoms, especially with new partners, and consider limiting the number of concurrent sexual partners.
• Stay hydrated and eat a balanced diet: Plenty of water and foods rich in prebiotic fiber (e.g., garlic, onions, bananas) support a healthy microbiome.
• Complete the full antibiotic course: Even if symptoms improve, stopping early can lead to recurrence.
• Track symptoms: Keep a brief diary of discharge, odor, and any irritation to discuss with your clinician.
• Follow‑up testing: A repeat vaginal swab 1‑2 weeks after treatment confirms eradication, especially in pregnancy.

Prevention

Preventive strategies focus on preserving the natural lactobaccharial environment:

• Avoid douching and intravaginal deodorants.
• Limit smoking or seek cessation programs.
• Use condoms consistently to reduce bacterial exchange.
• Consider probiotic‑rich foods (yogurt, kefir, fermented vegetables) or supplements after discussing with a healthcare provider.
• If you have recurrent BV, ask your clinician about regular maintenance therapy.

Complications

While often considered “benign,” untreated or recurrent BV—including its vegetative form—can lead to serious health outcomes:

• Pregnancy complications: Preterm labor, low birth weight, and premature rupture of membranes.^[3]
• Increased susceptibility to sexually transmitted infections (STIs): BV alters the mucosal barrier, raising the risk for chlamydia, gonorrhea, and HIV acquisition.^[6]
• Pelvic inflammatory disease (PID): Ascending infection can cause chronic pelvic pain and infertility.
• Post‑operative infections: Women undergoing gynecologic surgery have higher wound infection rates if BV is present.
• Urethral and urinary tract irritation: Chronic inflammation may predispose to recurrent UTIs.

When to Seek Emergency Care

References

1. Mayo Clinic. Bacterial vaginosis. Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. Bacterial Vaginosis Fact Sheet. 2022. https://www.cdc.gov
3. American College of Obstetricians and Gynecologists. Committee Opinion No. 797: Screening for Bacterial Vaginosis in Pregnancy. 2021.
4. World Health Organization. Guidelines for the Treatment of Reproductive Tract Infections. 2020.
5. Reid G, et al. Probiotic supplementation for the treatment of bacterial vaginosis: systematic review. *BJOG*. 2021;128(5):618‑627.
6. National Institute of Allergy and Infectious Diseases. Relationship Between BV and HIV Acquisition. 2022.